Sections 6001, 6002, and 6003 of the Deficit Reduction Act of 2005 (DRA) made significant changes to the Medicaid prescription drug provisions of the Social Security Act.  These changes include revising the definition of average manufacturer price (AMP), establishing a new formula for calculating Federal upper limits (FULs), requiring rebates for certain physician-administered drugs, and clarifying rebate liability for authorized generic drugs.  

We have provided several resources and documents that will help stakeholders understand the impact of these provisions on the Medicaid program and keep informed about how CMS is implementing these provisions.  These materials can be found on the Deficit Reduction Act web section by clicking on the link below.

Downloads
There are no Downloads
Related Links Inside CMS
Medicaid Prescription Drugs under the DRA CMS-2238-FC Medicaid Program: Prescription Drugs - Published July 17, 2007 CMS-2238-F Medicaid Program: Multiple Source Drug Definition - Published October 7, 2008
Related Links Outside CMS
There are no Related Links Outside CMS

Page Last Modified: 12/04/2008 11:17:26 AM
Help with File Formats and Plug-Ins